Company Overview and News

29
Semiconductor ETFs in Trouble?

2018-09-12 zacks - 2
iShares PHLX Semiconductor ETF (SOXX - Free Report) , the most popular semiconductor ETF, had record outflows of $393 million in the week ended Sep 7. Of this $259 million was pulled out on the day alone, the most since its inception in July 2001 (see: all Technology ETFs here). A nearly two-year brilliant run for the $121 billion global memory chip industry has now begun to slow down. The semiconductor space has faced stumbling blocks because of Nvidia’s (NVDA - Free Report) suspension of the self-driving car tests in March, trade tensions and the plunge in cryptocurrency prices.
SOXX AMAT AMD NVDA XSD QCOM

33
Top 7 Semiconductor ETFs to Buy Now

2018-09-12 investorplace
Semiconductor stocks are proving to be important drivers of the broader technology sector’s 2018 upside. Just look at the widely followed PHLX SOX Semiconductor Sector Index, which is up 9.60% year-to-date. Investors looking to profit should consider semiconductor ETFs.
SOXX TXN AMD NVDA FTXL MU MS QCOM INTC TSM

7
2 ETF and Stock Takeaways From Back-to-School Shopping Season

2018-08-27 investorplace
The back-to-school season, the shopping extravaganza between July and September that comes second to holiday shopping, is at its peak. Americans are estimated to spend $27.6 billion this time, per an article published on CNBC. Keeping this in mind, below we highlight a few patterns that have been established in this year’s back-to-school season.
DLTR SOXX TJX TGT DG FONE WMT

34
3 Great Semiconductor Stocks to Buy Now

2018-08-27 investorplace
Semiconductor stocks are having a bumpy 2018. While the sector is in the green overall, the chipmakers are trailing the Nasdaq Composite, as measured by the Invesco QQQ Trust (NASDAQ:QQQ) by a wide margin. The QQQ ETF is up 16% year-to-date, with the iShares PHLX Semiconductor ETF (NASDAQ:SOXX) up just half that for the year.
SOXX QQQ TXN AAPL NXPI AMD NVDA QCOM INTC

5
2 ETF & Stock Takeaways From Back-to-School Shopping Season

2018-08-27 zacks
The back-to-school season, the shopping extravaganza between July and September that comes second to holiday shopping, is at its peak. Americans are estimated to spend $27.6 billion this time, per an article published on CNBC. Keeping this in mind, below we highlight a few patterns that have been established in this year’s back-to-school season.
DLTR SOXX TJX TGT RTH DG

7
5 Top-Ranked Semiconductor Stocks For a Winning Portfolio

2018-08-23 zacks
Semiconductors are the building block of the technology sector as these find application in most of the day-to-day human requirements ranging from electronic gadgets to cars, planes and advanced weaponry. Robust demand for memory chips and other semiconductor products owing to the rapid adoption of cloud, Internet of Things (“IoT”), autonomous cars, advanced driver assisted systems (“ADAS”), gaming, wearables, drones, virtual reality/ augmented reality (“VR/AR”) devices, artificial intelligence (“AI”), and cryptocurrencies are fueling massive growth in the space.
SOJA SOXX STZ.B SO QRVO CY TXN VSH XSD STZ KLAC

28
Pick Nvidia Stock over Micron for Higher Risk and Higher Reward

2018-08-21 investorplace
The semiconductor sector has been one of the market’s hottest the past couple of years, and both Nvidia (NASDAQ:NVDA) and Micron (NASDAQ:MU) have benefited. Even with a recent pullback, Nvidia stock has gained a whopping 953% over the past three years. MU stock has “only” tripled over that period, but it trades about 5x higher than it did at May 2016 lows.
SOXX TXN HXSCF MU AMD NVDA INTC HXSCL

153
Stocks To Watch: Alibaba, Target And Energy Plays To Center Stage

2018-08-18 seekingalpha - 3
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
FOCS PDD LGCYP LGCYO QEP TJX EL AVGO ABBV FTNT KLXI CORR ESES SDPI TENB LNR RRS WPX FSBW ESTE NPTN ERF BABA SDCJF PAY MSFT GPS MPOYQ HRS FL MLM BLCN MOS SEA CLPS LB CLB ROSEU DBX CF CRDAF KSS CRDAD CI SSI JAG ROSE SNDE DAVA SJM UNT HUM EOG BHI RGRYY MU LGCY SBUX MNK WRD LOW JKS TOL LONE ERF CLB FTK AMAT CRD KEG KEGX SOXX STT FSWB WLL AQST SM LBRT BV LLEX ADIL NBR RGRLF CMG RRC INTU HIMX BJRI EDUC BE MPO ABBV BA ESRX ECR JG NDLS WPXP MTB RRL VMW ALRM LQDA RMBS ECA CANG ICD OPRA IBM WISA CDEV JGPK LYB COG ECA SPDI SBOW PHX TGT NTR BRY HPQ URBN TELL

6
Is Fading Crypto Demand At All a Threat to Semiconductor ETFs?

2018-08-17 zacks
The once-soaring semiconductor space had hit the wall this year with ETFs returning more-or-less 3% so far (as of Aug 16, 2018). Factors that thwarted growth in the space this year were news of Nvidia’s (NVDA - Free Report) suspension of self-driving car tests on public roads in March, heightened trade war talks between the United States and China and the slump in cryptocurrency price (read: Should You Snap Up Downtrodden Semiconductor ETFs Now?).
SOXX GOOGL MSFT NVDA GOOG

 
ETFs to Buy as NVIDIA Shares Dip on Bleak Outlook

2018-08-17 zacks
After the closing bell yesterday, NVIDIA NVDA) disappointed investors with its second-quarter fiscal 2019 results. Though the biggest maker of graphics processors beat the Zacks Consensus Estimate for both the top and the bottom lines, it provided bleak revenue guidance for the ongoing quarter, citing sudden decline in cryptocurrency-mining sales. Shares of NVDA dropped as much as 6.4% in aftermarket hours.
SOXX FNG

7
Nvidia Reports Approaching A New High At A Risky Level

2018-08-16 seekingalpha - 1
Nvidia is a momentum semiconductor stock that is approaching my monthly risky level of $269.65 which would be a new all-time intraday high if tested.
WFC WFCNP SOXX NVDA

4
Bitcoin Burst To Hit Semiconductors Soon

2018-08-11 seekingalpha
As processor prices return to normal levels, we expect revenue to miss estimates in upcoming earnings announcements.
SOXX AMAT AVGO NVDA MCHP

2
Semiconductor ETFs to Tap Intel's Dip Post Q2 Earnings

2018-07-27 zacks
Intel (INTC - Free Report) , the world’s largest chipmaker, reported stronger-than-expected Q2 results after the market closed yesterday. The company surpassed estimates for both revenues and earnings and increased its full-year outlook. However, revenue growth at its fastest-growing data center business came below analysts’ expectation and took a toll on shares (read: What's in Store for Chip ETFs in Q2 Earnings?).
SOXX INTC

 
China's Likely Retaliation to US Tariffs & Its Impact on ETFs

2018-07-24 zacks
We are now past the half-way mark of 2018 and trade tensions show no signs of slowing. The United States and China first targeted $50 billion worth of goods for import tariffs, then the Trump administration disclosed another list of tariffs on $200 billion worth of Chinese goods. Now President Trump intends to enact tariffs on all $505 billion of Chinese goods imported into the United States – the dollar value of U.
SOXX MS

8
What's in Store for Chip ETFs in Q2 Earnings?

2018-07-23 zacks
Despite the fact that semiconductor stocks are most vulnerable to trade tensions between the United States and China, this corner of the broad technology market is in focus currently (read: Chip ETFs Tumble as Trade Fears Intensify: Time to Buy?). Robust demand for memory chips and other semiconductor products owing to the rapid adoption of cloud, Internet of Things, autonomous cars, gaming, wearables, VR headsets, drones, virtual reality devices, artificial intelligence, cryptocurrencies, and other advanced information technologies are acting as major catalysts.
SOXX TXN AMAT NVDA QCOM INTC

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to SOXX / iShares PHLX Semiconductor ETF on message board site Silicon Investor.

Iu0027m a booted Sox (or is it Soxx?) clown... Iu0027m a booted Sox (or is it Soxx?) clown... Iu0027m a booted Sox (or is it Soxx?) clown...
CUSIP: 464287523